Voice your opinion on congressional bill HR2815-117 and let lawmakers know your stance with UnPac!

Main Subject: Health

Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act

This bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified.

HR7497-117, HR5376-117,

House committee actions Actions

Committee
Apr. 23 2021	Referred to the Subcommittee on Health.
Apr. 22 2021	Referred to the Subcommittee on Social Security. Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral

Apr. 22
2021

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Library of Congress Actions

IntroReferral
Apr. 22 2021	Introduced in House Introduced in House

House bill HR2815-117

BIOSIM Act

Promote the cause!

Or use this QR code